Stock Research for JNJ

Current Price

$133.3500


Latest Update: 2018-02-16 16:00:00

High
$ 133.3500
Low
$ 133.1000
Close
$ 133.1500
Volume
142931
 
  

Featured Broker: TradeStation

Get the due diligence for another stock.

 

JNJ Stock Chart & Research Data

The JNJ chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the JNJ chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


JNJ Due diligence Resources & Stock Charts

The JNJ stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View JNJ Detailed Price Forecast - CNN Money CNN View JNJ Detailed Summary - Google Finance
Yahoo View JNJ Detailed Summary - Yahoo! Finance Zacks View JNJ Stock Research & Analysis - Zacks.com


Stock Analysis

TradeIdeas View JNJ Trends & Analysis - Trade-Ideas Barrons View JNJ Major Holders - Barrons
NASDAQ View JNJ Call Transcripts - NASDAQ Seeking View JNJ Breaking News & Analysis - Seeking Alpha
Spotlight View JNJ Annual Report - CompanySpotlight.com OTC Report View JNJ OTC Short Report - OTCShortReport.com
TradeKing View JNJ Fundamentals - TradeKing Charts View JNJ SEC Filings - Bar Chart
WSJ View Historical Prices for JNJ - The WSJ Morningstar View Performance/Total Return for JNJ - Morningstar
MarketWatch View the Analyst Estimates for JNJ - MarketWatch CNBC View the Earnings History for JNJ - CNBC
StockMarketWatch View the JNJ Earnings - StockMarketWatch MacroAxis View JNJ Buy or Sell Recommendations - MacroAxis
Bullish View the JNJ Bullish Patterns - American Bulls Short Pains View JNJ Short Pain Metrics - ShortPainBot.com


Social Media Mentions

StockTwits View JNJ Stock Mentions - StockTwits PennyStocks View JNJ Stock Mentions - PennyStockTweets
Twitter View JNJ Stock Mentions - Twitter Invest Hub View JNJ Investment Forum News - Investor Hub
Yahoo View JNJ Stock Mentions - Yahoo! Message Board Seeking Alpha View JNJ Stock Mentions - Seeking Alpha




Financial & Transaction Holdings

SECform4 View Insider Transactions for JNJ - SECform4.com Insider Cow View Insider Transactions for JNJ - Insider Cow
CNBC View JNJ Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for JNJ - OTC Markets
Yahoo View Insider Transactions for JNJ - Yahoo! Finance NASDAQ View Institutional Holdings for JNJ - NASDAQ


Stock Charts

FinViz View JNJ Stock Insight & Charts - FinViz.com StockCharts View JNJ Investment Charts - StockCharts.com
BarChart View JNJ Stock Overview & Charts - BarChart Trading View View JNJ User Generated Charts - Trading View


Latest Financial News for JNJ

See what the IHS Markit Score report has to say about Johnson & Johnson.
Posted on Tuesday February 20, 2018

Johnson & Johnson NYSE:JNJ


J&J Is Exploring a Sale of Its $2 Billion Sterilization Division
Posted on Monday February 19, 2018

Johnson & Johnson is seeking buyers for its sterilization products division, people familiar with the matter said, as the health-care conglomerate continues to sell off non-core assets.


Analysts’ Recommendations for Merck & Co. after 4Q17
Posted on Monday February 19, 2018

Must-Read Notes on Merck & Co.’s 4Q17 and 2017 Earnings


Merck’s Valuations after Its 4Q17 Earnings
Posted on Monday February 19, 2018

Must-Read Notes on Merck & Co.’s 4Q17 and 2017 Earnings


Your Daily Pharma Scoop: AbbVie's Upadacitinib, Johnson & Johnson's Tremfya ...
Seeking Alpha - Feb 19, 2018
Today we will discuss AbbVie (ABBV), which continues to have a phenomenal run in 2018 even as sentiment on the broader equity market has turned negative.

Berko: Johnson & Johnson has a bright future (and talcum powder is safe)
Columbus Business First - Feb 19, 2018
Dear Mr. Berko: I bought 300 shares of Johnson & Johnson on your recommendation at $106 in April 2017 and have a 23-point profit.

Johnson & Johnson falls on report that lawsuits could expose potentially ...
CNBC - Feb 5, 2018
Johnson & Johnson falls on report that lawsuits could expose potentially damaging documents. Johnson & Johnson's stock fell on a report that court proceedings could expose potentially damaging documents. J&J is facing numerous lawsuits claiming its ...
Johnson & Johnson falls on report that lawsuits could expose damaging documents - ABC10
Johnson & Johnson Mesothelioma Trial Likely to Expose Company Documents - Mesothelioma.net Blog (blog)

Johnson & Johnson falls on 'disappointing' sales outlook
CNBC - Jan 23, 2018
Shares of Johnson & Johnson turned negative as investors reacted to a lackluster sales growth outlook. The company topped Wall Street's fourth-quarter earnings and revenue expectations with boosts from new cancer drugs and its acquisition of Swiss ...
Johnson & Johnson loses $10.7B after sweeping US tax changes - Chicago Tribune

Enter a stock symbol to view the stock details.